Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2203
https://www.valueinhealthjournal.com/article/S1098-3015(14)04133-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1661
First Page :
A621
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04133-3&doi=10.1016/j.jval.2014.08.2203